Skip to search formSkip to main contentSkip to account menu

STS 557

Known as: STS-557 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
This paper reports on pharmacological properties of 17 alpha-cyano-methyl-17 beta-hydroxy-estra-4, 9-dien-3-one (STS 557), which… 
2009
2009
Transformation of STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4, 9-dien-3-one) by female rat liver microsomes… 
2009
2009
Following oral and i.v. administration of [14 alpha, 15 alpha-3H]-STS 557 to beagle dogs, baboons, rats and female volunteers… 
2009
2009
STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4, 9-dien-3-one) or levonorgestrel was given orally as a single dose of 0.4… 
2009
2009
STS 557 was tested for adverse effects in mice by prenatal and postnatal investigations. Several doses of STS 557 and… 
1990
1990
Treatment with STS-557 (17 alpha-cyanomethyl 17 beta-hydroxy-estra-4,9(10)-dien-3-one; 10 mg kg-1 daily s.c.) for 4 weeks induced… 
1983
1983
Treatment with 1.0 mg of STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4.9 (10)-diene-3-one) daily for 3 weeks had no… 
1982
1982
STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one) or levonorgestrel was given orally as a single dose of 0…